Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone improved symptoms in women with hormonal imbalances and had few side effects.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Spironolactone and finasteride are equally effective for hirsutism in transgender women.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

Hormones, especially androgens, play a key role in causing acne, and treatments like hormone control pills and hormone-blocking medications can help.

Anti-androgens can help reduce the effects of male hormones on the skin.

Hair analysis can help diagnose adrenal disorders non-invasively.

Spironolactone and clascoterone are promising acne treatments with fewer side effects.

Bicalutamide is more effective and safer than spironolactone for treating female hair loss.

Low-dose spironolactone can be effective for treating hair loss in women.

Spironolactone is effective and safe for treating hair loss, excessive hair growth, and acne.

New treatments for excessive hair growth in women, including advanced drugs and nanotechnology, show promise for better results.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Both minoxidil-spironolactone and minoxidil-finasteride treatments work for hair loss, but minoxidil-spironolactone is slightly more effective, especially in women.

Common baldness is a hereditary condition that can be treated with medications or surgery to prevent progression and improve self-esteem.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

Topical imiquimod use for treating a cervical lesion might cause delayed hair loss.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

A woman's hair loss was linked to a rare hormone-secreting ovarian tumor, treated with surgery and hair loss medication.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

A patient with HAIR-AN syndrome, PCOS, and Hashimoto's thyroiditis improved with early diagnosis and treatment to prevent serious health problems.

Older men with scalp wounds had long-term healing problems after using imiquimod or diclofenac for skin cancer prevention.

Certain drugs can cause skin lupus, but stopping the drug usually helps. Vaccines work against smallpox, genital herpes, and a type of human papillomavirus. More frequent light therapy clears psoriasis faster. Certain treatments work for psoriasis and dermatitis. A specific cream effectively treats a type of skin cancer. Low iron levels aren't directly linked to chronic hair loss.

Hair loss in women can be treated with hormone therapy.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Spironolactone is more effective than finasteride in treating excessive hair growth in women.

Treatment improved symptoms in a woman with HAIR-AN syndrome.

Spironolactone helped reduce excessive facial hair in a woman with porphyria cutanea tarda.